Encore Medical aims to raise $17.25M in IPO funding for FDA heart device trials. Click here to read the latest analysis on EMI stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback